UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 13, 2007
AQUACELL TECHNOLOGIES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-16165 33-0750453
------------------------------ ------------- ------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
10410 Trademark Street, Rancho Cucamonga, CA 91730
---------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(909) 987-0456
--------------------------------------------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(e))
ITEM 7.01. Regulation FD Disclosure.
The registrant will provide information as part of an investor presentation
regarding its pending acquisition of Sky Electronics, Inc., growth strategy and
markets. The registrant's slide presentation, that includes limited financial
information, is annexed as an exhibit to this filing.
Statements about the Company's future expectations, including the
acquisition of Sky Electronics, Inc. future revenues and earnings, and all other
statements in this presentation other than historical facts, are "forward-
looking statements" within the meaning of Section 27A of the Securities Act of
1933, Section 21E of the Securities Exchange Act of 1934, and as that term is
defined in the Private Securities Litigation Reform Act of 1995. While these
statements are made to convey to the public the Company's progress, business
opportunities and growth prospects, readers and listeners are cautioned that
such forward-looking statements represent management's opinion. Whereas
management believes such representations to be true and accurate based on
information and data available to the Company at this time, the Company intends
that such forward-looking statements be subject to the safe harbors created
thereby. Since these statements involve risks and uncertainties and are subject
to change at any time, the Company's actual results could differ materially from
expected results. Important factors that may cause actual results to differ are
set forth in the Company's periodic filings with the US Securities and Exchange
Commission.
ITEM 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 AquaCell Technologies, Inc. Investor Presentation dated
March, 2007
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AQUACELL TECHNOLOGIES, INC.
Date: March 13, 2007 By: /s/ Karen B. Laustsen
------------------------------------
Karen B. Laustsen
Secretary